Degarelix Accord Európai Unió - magyar - EMA (European Medicines Agency)

degarelix accord

accord healthcare s.l.u. - degarelix acetate - prosztatikus daganatok - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Firmagon Európai Unió - magyar - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelixet - prosztatikus daganatok - endokrin terápia - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Ganirelix Gedeon Richter Európai Unió - magyar - EMA (European Medicines Agency)

ganirelix gedeon richter

chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - hipofízis és hypothalamus hormonok és analógok - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).